Cover Image

A case report of steriod induced cataract

Govindan M .

Abstract


Prolonged use of glucocorticoids is a significant risk factor for the development of posterior subcapsular         cataract. This places restrictions on the use of glucocorticoids in the treatment of systemic andor ocular inflammatory             conditions as well as in organ transplantation. Steroid-induced posterior subcapsular cataracts (PSCs) exhibit three main distinctive characteristics (i) association only with steroids possessing glucocorticoid activity, (ii) involvement of aberrant migrating lens epithelial cells, and (iii) a central posterior    location

Full Text:

PDF

References


Thylefors B, NCgrel AD, PararajasegaramR, Dadzie W, Global data on blindness. Bull W O 1995; 73: 115121

Harding J, ed. Cataract: BiochemistryEpidemiology and Pharmacology. London: M Chapman and Hall, 1991; 83-124.

Urban RC Jnr, Cotlier E. Corticosteroidinduced cataracts. Sun, Ophthalmol1986; 31:102-110.

Oglesby RB, Black RL, von Sallmann L, Bunim JJ. Cataracts in rheumatoid arthritispatients treated with corticosteroids. Arch Ophthalmoll961; 66: 519-523.

Crews SJ. Posterior subcapsular lens opacities in patients on long-term corticosteroidtherapy. Br Med J 1963; 5346: 16441647.

Fryer JP, Granger DK, Leventhal JR,Gillingham K, Najarian JS, Matas AJ.Steroidrelated complications in the cyclosporine era. Clin Transplant 1994; 8:224229


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr MGR Medical University